These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 31113483)
1. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma. Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326 [TBL] [Abstract][Full Text] [Related]
3. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056 [TBL] [Abstract][Full Text] [Related]
4. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma]. Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy. Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886 [TBL] [Abstract][Full Text] [Related]
6. High hepatitis B virus infection in B-cell lymphoma tissue and its potential clinical relevance. Wang F; Yuan S; Teng KY; Garcia-Prieto C; Luo HY; Zeng MS; Rao HL; Xia Y; Jiang WQ; Huang HQ; Xia ZJ; Sun XF; Xu RH Eur J Cancer Prev; 2012 May; 21(3):261-7. PubMed ID: 22433629 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies. Li M; Gan Y; Fan C; Yuan H; Zhang X; Shen Y; Wang Q; Meng Z; Xu D; Tu H J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605 [TBL] [Abstract][Full Text] [Related]
8. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363 [TBL] [Abstract][Full Text] [Related]
9. Clinical analysis of stages of HBV infection in 100 cases of lymphoma. Tang Y; Sun LG; Liu CS; Li YY; Jin CH; Li D; Bai O Asian Pac J Cancer Prev; 2013; 14(2):959-62. PubMed ID: 23621268 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Engels EA; Cho ER; Jee SH Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564 [TBL] [Abstract][Full Text] [Related]
11. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study. Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus infection and the risk of cancer among the Chinese population. Tian T; Song C; Jiang L; Dai J; Lin Y; Xu X; Yu C; Ge Z; Ding Y; Wen Y; Liu B; Shao Y; Shi P; Zhu C; Liu Y; Jing S; Wang Z; Hu Z; Li J Int J Cancer; 2020 Dec; 147(11):3075-3084. PubMed ID: 32478856 [TBL] [Abstract][Full Text] [Related]
14. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin. Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957 [TBL] [Abstract][Full Text] [Related]
16. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort. Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism. van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies. Dalia S; Chavez J; Castillo JJ; Sokol L Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583 [TBL] [Abstract][Full Text] [Related]
20. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment]. Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]